BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 29027231)

  • 1. The renaissance of anti-neoplastic immunity from tumor cell demise.
    Ma Y; Pitt JM; Li Q; Yang H
    Immunol Rev; 2017 Nov; 280(1):194-206. PubMed ID: 29027231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses.
    Garg AD; Agostinis P
    Immunol Rev; 2017 Nov; 280(1):126-148. PubMed ID: 29027218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagic Mechanism in Anti-Cancer Immunity: Its Pros and Cons for Cancer Therapy.
    Li YY; Feun LG; Thongkum A; Tu CH; Chen SM; Wangpaichitr M; Wu C; Kuo MT; Savaraj N
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment.
    Pitt JM; Kroemer G; Zitvogel L
    Adv Exp Med Biol; 2017; 1036():65-79. PubMed ID: 29275465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.
    Tang R; Xu J; Zhang B; Liu J; Liang C; Hua J; Meng Q; Yu X; Shi S
    J Hematol Oncol; 2020 Aug; 13(1):110. PubMed ID: 32778143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Necroptotic cell death in anti-cancer therapy.
    Krysko O; Aaes TL; Kagan VE; D'Herde K; Bachert C; Leybaert L; Vandenabeele P; Krysko DV
    Immunol Rev; 2017 Nov; 280(1):207-219. PubMed ID: 29027225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance.
    Bloy N; Garcia P; Laumont CM; Pitt JM; Sistigu A; Stoll G; Yamazaki T; Bonneil E; Buqué A; Humeau J; Drijfhout JW; Meurice G; Walter S; Fritsche J; Weinschenk T; Rammensee HG; Melief C; Thibault P; Perreault C; Pol J; Zitvogel L; Senovilla L; Kroemer G
    Immunol Rev; 2017 Nov; 280(1):165-174. PubMed ID: 29027230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation Therapy and the In Situ Vaccination Approach.
    Golden EB; Marciscano AE; Formenti SC
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):891-898. PubMed ID: 32800803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of abscopal anti-tumor immunity and immunogenic tumor cell death by ionizing irradiation - implications for cancer therapies.
    Frey B; Rubner Y; Wunderlich R; Weiss EM; Pockley AG; Fietkau R; Gaipl US
    Curr Med Chem; 2012; 19(12):1751-64. PubMed ID: 22414083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-induced microenvironmental changes in cancer.
    Ma Y; Yang H; Pitt JM; Kroemer G; Zitvogel L
    J Mol Med (Berl); 2016 May; 94(5):497-508. PubMed ID: 26931513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Induction of Immunogenic Cell Death and Interferon Expression in Cancer Cells by Structured ssRNAs.
    Lee J; Lee Y; Xu L; White R; Sullenger BA
    Mol Ther; 2017 Jun; 25(6):1295-1305. PubMed ID: 28372998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stress-induced cellular responses in immunogenic cell death: Implications for cancer immunotherapy.
    Radogna F; Diederich M
    Biochem Pharmacol; 2018 Jul; 153():12-23. PubMed ID: 29438676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunoprevention: a new approach to intercept cancer early.
    Umar A
    Cancer Prev Res (Phila); 2014 Nov; 7(11):1067-71. PubMed ID: 25237055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Programmed Cell Death Tunes Tumor Immunity.
    Liu J; Hong M; Li Y; Chen D; Wu Y; Hu Y
    Front Immunol; 2022; 13():847345. PubMed ID: 35432318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Necroptosis in tumorigenesis, activation of anti-tumor immunity, and cancer therapy.
    Meng MB; Wang HH; Cui YL; Wu ZQ; Shi YY; Zaorsky NG; Deng L; Yuan ZY; Lu Y; Wang P
    Oncotarget; 2016 Aug; 7(35):57391-57413. PubMed ID: 27429198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenic cell death modalities and their impact on cancer treatment.
    Kepp O; Tesniere A; Schlemmer F; Michaud M; Senovilla L; Zitvogel L; Kroemer G
    Apoptosis; 2009 Apr; 14(4):364-75. PubMed ID: 19145485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune response against dying tumor cells: avoid disaster, achieve cure.
    Zitvogel L; Kroemer G
    Cell Death Differ; 2008 Jan; 15(1):1-2. PubMed ID: 18084310
    [No Abstract]   [Full Text] [Related]  

  • 19. Pyroptotic and Necroptotic Cell Death in the Tumor Microenvironment and Their Potential to Stimulate Anti-Tumor Immune Responses.
    Scarpitta A; Hacker UT; Büning H; Boyer O; Adriouch S
    Front Oncol; 2021; 11():731598. PubMed ID: 34490126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune surveillance and anti-tumor immune responses: an anatomical perspective.
    Zimmermann VS; Benigni F; Mondino A
    Immunol Lett; 2005 Apr; 98(1):1-8. PubMed ID: 15790503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.